GlassScriptPhysician profile
Jennifer B Oconnor
NPI 1790788594
$7,173.14
in general payments reported to CMS, 2019-2025
40 companies · $1,345 in 2025
The $1,345 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $636 · 2021: $1,062 · 2022: $949 · 2023: $1,320 · 2024: $1,353 · 2025: $1,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,018.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,287.64 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $815.44 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $743.11 | 2019-2025 | |
| Abbvie INC. | $742.51 | 2021-2025 | |
| Astellas Pharma US INC | $386.56 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $375.95 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $281.14 | 2020-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $268.51 | 2021-2025 | |
| Daiichi Sankyo INC. | $222.50 | 2020-2025 | Injectafer |
| Amgen INC. | $187.63 | 2019-2025 | Repatha, Otezla |
| Exact Sciences Corporation | $150.60 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.56 | 2022-2025 | Xifaxan |
| Allergan, INC. | $140.74 | 2019-2021 | |
| Abbott Laboratories | $138.34 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $135.03 | 2019-2023 | Spravato |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.